Diabetes Drugs: Bittersweet Truth of Patent Expiries
The Morning Brief
00:00
Genovia and Istemate - Is There Any Potential of Them in India?
Genuvia was something that actually established the presence of murk in india. Sitagliptin is not going to be like, a huge story for the patient ine. But as a product itself, i don't think the doctors will want to make a switch from an existing patient with already on some other difiti for to genuvia.
Play episode from 08:03
Transcript
